LAG3 and Autoimmunity: Several formulations have been explored, including soluble dimeric LAG-3 as an adjuvant, agonist antibodies that block the interaction between this receptor and its ligands, antibody-mediated LAG-3 cell depletion in autoimmunity, and finally, the use of small molecule GSK-3 to modulate LAG-3 expression [123].